A taxonomy for disease management - A scientific statement from the American Heart Association Disease Management Taxonomy Writing Group

被引:201
|
作者
Krumholz, Harlan M.
Currie, Peter M.
Riegel, Barbara
Phillips, Christopher O.
Peterson, Eric D.
Smith, Renee
Yancy, Clyde W.
Faxon, David P.
机构
关键词
AHA Scientific Statements; disease management; chronic disease; delivery of health care; classification; heart failure;
D O I
10.1161/CIRCULATIONAHA.106.177322
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Disease management has shown great promise as a means of reorganizing chronic care and optimizing patient outcomes. Nevertheless, disease management programs are widely heterogeneous and lack a shared definition of disease management, which limits our ability to compare and evaluate different programs. To address this problem, the American Heart Association's Disease Management Taxonomy Writing Group developed a system of classification that can be used both to categorize and compare disease management programs and to inform efforts to identify specific factors associated with effectiveness. Methods-The AHA Writing Group began with a conceptual model of disease management and its components and subsequently validated this model over a wide range of disease management programs. A systematic MEDLINE search was performed on the terms heart failure, diabetes, and depression, together with disease management, case management, and care management. The search encompassed articles published in English between 1987 and 2005. We then selected studies that incorporated (1) interventions designed to improve outcomes and/or reduce medical resource utilization in patients with heart failure, diabetes, or depression and (2) clearly defined protocols with at least 2 prespecified components traditionally associated with disease management. We analyzed the study protocols and used qualitative research methods to develop a disease management taxonomy with our conceptual model as the organizing framework. Results-The final taxonomy includes the following 8 domains: (1) Patient population is characterized by risk status, demographic profile, and level of comorbidity. (2) Intervention recipient describes the primary targets of disease management intervention and includes patients and caregivers, physicians and allied healthcare providers, and healthcare delivery systems. (3) Intervention content delineates individual components, such as patient education, medication management, peer support, or some form of postacute care, that are included in disease management. (4) Delivery personnel describes the network of healthcare providers involved in the delivery of disease management interventions, including nurses, case managers, physicians, pharmacists, case workers, dietitians, physical therapists, psychologists, and information systems specialists. (5) Method of communication identifies a broad range of disease management delivery systems that may include in-person visitation, audiovisual information packets, and some form of electronic or telecommunication technology. (6) Intensity and complexity distinguish between the frequency and duration of exposure, as well as the mix of program components, with respect to the target for disease management. (7) Environment defines the context in which disease management interventions are typically delivered and includes inpatient or hospital-affiliated outpatient programs, community or home-based programs, or some combination of these factors. (8) Clinical outcomes include traditional, frequently assessed primary and secondary outcomes, as well as patient-centered measures, such as adherence to medication, self-management, and caregiver burden. Conclusions-This statement presents a taxonomy for disease management that describes critical program attributes and allows for comparisons across interventions. Routine application of the taxonomy may facilitate better comparisons of structure, process, and outcome measures across a range of disease management programs and should promote uniformity in the design and conduct of studies that seek to validate disease management strategies.
引用
收藏
页码:1432 / 1445
页数:14
相关论文
共 50 条
  • [31] Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease A Scientific Statement for Health Professionals From the American Heart Association
    McCrindle, Brian W.
    Rowley, Anne H.
    Newburger, Jane W.
    Burns, Jane C.
    Bolger, Anne F.
    Gewitz, Michael
    Baker, Annette L.
    Jackson, Mary Anne
    Takahashi, Masato
    Shah, Pinak B.
    Kobayashi, Tohru
    Wu, Mei-Hwan
    Saji, Tsutomu T.
    Pahl, Elfriede
    CIRCULATION, 2017, 135 (17) : E927 - E999
  • [32] Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association
    Mac Grory, Brian
    Schrag, Matthew
    Biousse, Valerie
    Furie, Karen L.
    Gerhard-Herman, Marie
    Lavin, Patrick J.
    Sobrin, Lucia
    Tjoumakaris, Stavropoula I.
    Weyand, Cornelia M.
    Yaghi, Shadi
    STROKE, 2021, 52 (06) : e282 - e294
  • [33] Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association
    Kittleson, Michelle M.
    Maurer, Mathew S.
    Ambardekar, Amrut V.
    Bullock-Palmer, Renee P.
    Chang, Patricia P.
    Eisen, Howard J.
    Nair, Ajith P.
    Nativi-Nicolau, Jose
    Ruberg, Frederick L.
    CIRCULATION, 2020, 142 (01) : E7 - E22
  • [34] Recognition and Initial Management of Fulminant Myocarditis A Scientific Statement From the American Heart Association
    Kociol, Robb D.
    Cooper, Leslie T.
    Fang, James C.
    Moslehi, Javid J.
    Pang, Peter S.
    Sabe, Marwa A.
    Shah, Ravi V.
    Sims, Daniel B.
    Thiene, Gaetano
    Vardeny, Orly
    CIRCULATION, 2020, 141 (06) : E69 - E92
  • [35] Diagnosis and Management of Cerebral Venous Thrombosis: A Scientific Statement From the American Heart Association
    Saposnik, Gustavo
    Bushnell, Cheryl
    Coutinho, Jonathan M.
    Field, Thalia S.
    Furie, Karen L.
    Galadanci, Najibah
    Kam, Wayneho
    Kirkham, Fenella C.
    McNair, Norma D.
    Singhal, Aneesh B.
    Thijs, Vincent
    Yang, Victor X. D.
    STROKE, 2024, 55 (03) : E77 - E90
  • [36] Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association
    Carey, Robert M.
    Calhoun, David A.
    Bakris, George L.
    Brook, Robert D.
    Daugherty, Stacie L.
    Dennison-Himmelfarb, Cheryl R.
    Egan, Brent M.
    Flack, John M.
    Gidding, Samuel S.
    Judd, Eric
    Lackland, Daniel T.
    Laffer, Cheryl L.
    Newton-Cheh, Christopher
    Smith, Steven M.
    Taler, Sandra J.
    Textor, Stephen C.
    Turan, Tanya N.
    White, William B.
    HYPERTENSION, 2018, 72 (05) : E53 - E90
  • [38] The role of endomyocardial biopsy in the management of cardiovascular disease - A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology
    Cooper, Leslie T.
    Baughman, Kenneth L.
    Feldman, Arthur M.
    Frustaci, Andrea
    Jessup, Mariell
    Kuhl, Uwe
    Levine, Glenn N.
    Narula, Jagat
    Starling, Randall C.
    Towbin, Jeffrey
    Virmani, Renu
    CIRCULATION, 2007, 116 (19) : 2216 - 2233
  • [39] The role of endomyocardial biopsy in the management of cardiovascular disease - A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology
    Cooper, Leslie T.
    Baughman, Kenneth L.
    Feldman, Arthur M.
    Frustaci, Andrea
    Jessup, Mariell
    Kuhl, Uwe
    Levine, Glenn N.
    Narula, Jagat
    Starling, Randall C.
    Towbin, Jeffrey
    Virmani, Renu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (19) : 1914 - 1931
  • [40] Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association
    Pierpont, Mary Ella
    Brueckner, Martina
    Chung, Wendy K.
    Garg, Vidu
    Lacro, Ronald V.
    McGuire, Amy L.
    Mital, Seema
    Priest, James R.
    Pu, William T.
    Roberts, Amy
    Ware, Stephanie M.
    Gelb, Bruce D.
    Russell, Mark W.
    CIRCULATION, 2018, 138 (21) : E653 - E711